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Acute meningoencephalitis (AME) is associated with considerable morbidity and mortality in children in developing countries.
Clinical specimens were collected from children presenting with AME at two Cambodian paediatric hospitals to determine the
major aetiologies associated with AME in the country. Cerebrospinal fluid (CSF) and blood samples were screened by molecular
and cell culture methods for a range of pathogens previously associated with AME in the region. CSF and serum (acute and
convalescent) were screened for antibodies to arboviruses such as Japanese encephalitis virus (JEV), dengue virus (DENV),
and chikungunya virus (CHIKV). From July 2010 through December 2013, 1160 children (one month to 15 years of age)
presenting with AME to two major paediatric hospitals were enroled into the study. Pathogens associated with AME were
identified using molecular diagnostics, cell culture and serology. According to a diagnostic algorithm, a confirmed or highly
probable aetiologic agent was detected in 35.0% (n=406) of AME cases, with a further 9.2% (total: 44.2%, n=513)
aetiologies defined as suspected. JEV (24.4%, n=283) was the most commonly identified pathogen followed by Orientia
tsutsugamushi (4.7%, n=55), DENV (4.6%, n=53), enteroviruses (3.5%, n=41), CHIKV (2.0%, n=23) and Streptococcus
pneumoniae (1.6%, n=19). The majority of aetiologies identified for paediatric AME in Cambodia were vaccine preventable
and/or treatable with appropriate antimicrobials.
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INTRODUCTION
Meningitis and encephalitis are infections of the meninges and brain,
respectively, and are major causes of mortality and long-term
neurological sequelae, particularly in children throughout the devel-
oping world. As these illnesses are difficult to clinically diagnose, they
are often grouped under the term acute meningoencephalitis (AME).
AME is among the most frequent and severe causes of pediatric
hospitalization across Asia.1
Bacterial meningitis is a serious condition; about 10% of patients
die even with adequate and timely antibiotic treatment, whereas the
fatality rate can rise to 40%–58% when access to prompt treatment is
unavailable.2 Many children who survive the infection are left with
permanent neurological impairments such as hearing loss, learning
disabilities, and behavioural problems.3 The burden of these sequelae
is unknown. It has been estimated that 16 million cases of acute
bacterial meningitis, resulting in approximately 300 000 deaths, occur
throughout the world each year, the vast majority in developing
countries.4,5 Haemophilus influenzae type b, Streptococcus pneumoniae
and Neisseria meningitidis account for ~ 80% of reported cases of
bacterial meningitis.4
The viral agents of meningitis and encephalitis vary greatly between
countries, with herpesviruses being the major aetiology in developed
countries and vector-borne pathogens being dominant in tropical
developing countries.6 Japanese encephalitis virus (JEV) has been
reported as the main cause of AME in Southeast Asia, with a
conservative estimate of 68 000 cases occurring annually.7,8 Children
in developing countries bear the greatest burden of morbidity and
mortality from AME infections, particularly in Southeast Asia where
important encephalitic pathogens such as JEV, enterovirus 71 (EV-
A71) and dengue virus (DENV) commonly circulate.
Cambodia (population 15.1 million) is one of the poorest countries
in Asia (Gross Domestic Product per capita of $1100 USD per
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annum).9 There has been no systematic report published about the
causes of AME in Cambodian children, although it is thought that
JEV, DENV and tuberculosis are common aetiologies.10,11 Due to the
absence of sufficient diagnostic capacity in most hospitals, Cambodian
clinicians commonly treat AME empirically with little evaluation of
the effectiveness of their clinical approach. The aim of this study was
to better define the major aetiologies of paediatric AME in Cambodia
through a prospective hospital-based study from 2010 to 2013.
MATERIALS AND METHODS
Patients and clinical specimens
Kantha Bopha hospitals represent the largest paediatric hospital
network in Cambodia, with an estimated 90% of all hospital care
delivered to Cambodian children in these hospitals. The two major
paediatric hospitals in the Southwest and Northeast of the country
were included in the study: Kantha Bopha Children’s Hospital in
Phnom Penh and Jayavarman VII Hospital in Siem Reap, respectively.
Children were admitted into the study from July 2010 until the end
of December 2013. Each week, an average of five children were
randomly selected to be enroled into the study among patients aged
41 month and o15 years who presented with clinical status that
required a lumbar puncture for which the admission diagnosis was
AME. Basic demographic information was collected from all patients
using case report forms. AME was defined as the presence of the
following criteria:
 Fever 438 °C, or febrile episode reported within the previous
month.
 Cerebrospinal fluid (CSF) abnormalities (4four white blood cells
per mm3 or CSF proteins 40.4 g/L).
 At least one of the following signs: confusion; prolonged, altered
consciousness; seizures; central neurological deficiency.
The study started with Jayavarman VII Hospital in Siem Reap in
July 2010, and in order to have a better representativeness of the
epidemiology of AME in the country Kantha Bopha Hospital in
Phnom Penh was included during 2013. The hospital in Phnom Penh
was not included in early recruitment of cases as the hospital was not
equipped with a magnetic resonance imaging system until 2012.
For virological and microbiological testing, the following specimens
were obtained during the first two days of admission: EDTA-
anticoagulated blood (2 mL minimum); clotted whole blood (1 mL);
CSF (2 mL collected during routine investigations); throat and rectal
swabs in viral transport medium (VTM). Blood and CSF culture for
bacteria isolation was also performed onsite in the hospitals according
to standard procedures. All samples were collected from patients based
on the medical judgement of individual clinicians as part of the
patient’s care management process. Specimens were kept at 4 °C after
sampling and transported daily to the laboratory at the Institut Pasteur
du Cambodge. Upon arrival in the laboratory, the specimens were
immediately processed and frozen at − 80 °C until further analysis.
Molecular biology testing
Nucleic acids were extracted from all clinical samples using the MagNa
Pure LC system (Roche Life Science, North Ryde, NSW, Australia),
according to the manufacturer’s instructions. Previously described
PCR/RT-PCR (real-time and conventional) methods were used
to screen for a large range of viral and bacterial pathogens
(Supplementary Table S1), including the viruses: JEV, DENV1-4,
chikungunya virus (CHIKV), flavivirus universal, EV-A71, enterovirus
universal, influenza A viruses, Epstein-Barr virus (EBV),
cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-
zoster virus (VZV); and the bacteria: S. pneumoniae, H. influenzae,
N. meningitidis, Orientia tsutsugamushi and Streptococcus suis. Myco-
bacterium tuberculosis testing was also undertaken using GeneXpert for
the first 40 patients enroled with a high clinical suspicion of
tuberculosis AME, but testing was discontinued due to the require-
ment for high volumes of CSF and the absence of positive results.
Testing of other pathogens (for example, rabies, measles and mumps)
was conducted if the clinical presentation was suggestive of a particular
infection.
Serological testing
All acute sera, convalescent sera and CSF samples were tested for anti-
JEV, -DENV and -CHIKV IgM using in-house capture enzyme-linked
immunosorbent assays (MAC-ELISA) as originally described by Rossi
and Ksiazek12 and adapted for our laboratory as outlined
previously.13,14 A result was considered positive when the optical
density (OD) of the sample was greater than the mean OD of three
negative control samples plus three standard deviations. An acute
infection was defined as an IgM seroconversion or a significant
increase of the OD measured between admission and discharge sera.
To rule out the possibility of contamination of the CSF with blood
IgM during sampling, CSF samples were only considered positive
when the OD was higher than the respective blood IgM OD reading.
In cases where both JEV and DENV IgM were detected positive the
result was recorded as positive for undifferentiated flavivirus.
Cell culture isolation
All CSF and serum samples that tested positive by PCR or serology for
JEV, CHIKV, DENV and flaviviruses were inoculated onto C6/36
(Aedes albopictus) cells in order to isolate the virus for subsequent
analysis. In addition, CSF was inoculated onto Vero E6 (African green
monkey kidney epithelial) cells from all patients when there was
sufficient CSF samples remaining after molecular and serological
testing.
Testing algorithm and decision tree
A diagnostic algorithm (Figure 1) was designed to define the
aetiological link between the detection of pathogens using different
methodologies. Aetiology was considered ‘confirmed’, ‘highly prob-
able’ or ‘suspected’ according to the criteria outlined in Figure 1.
Aetiology was classified as unknown for cases in which all tests were
negative. In cases where there was conflicting results between different
tests a decision tree (Figure 2) was used to decide on the final aetiology
of the AME.
We defined the molecular detection of CMV and EBV in the CSF as
a ‘highly probable’ aetiology due to the unknown frequency in which
these viruses can reactivate from latent infection and be detected in the
CSF without being the cause of AME. However, only cases where virus
was detected above a threshold of 100 copies were included as positive
aetiologies.
Representation and mapping of JEV cases
Clinical data were entered using Excel (Microsoft Corp, Redwoods,
WA, USA) and explored by province of patient residence using
STATA 11 (StataCorp, College Station, TX, USA). Confirmed cases
were represented by month in a graph using Excel along with mean
rainfall data estimated by satellite teledetection (Tropical Rainfall
Measuring Mission, NASA, USA, http://trmm.gsfc.nasa.gov/) and
adjusted for surface of province of residence. Population-adjusted
attack rates (cases per 100 000 pop, using 2012 population) for each
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study period (2010–2012 and 2013) were mapped using ArcGIS 10
(Esri, Redlands, CA, USA), by year and patient’s province of residence,
to assess the time and geographical distribution of all ‘confirmed’ and
‘highly probable’ JEV cases for which sufficient information for date of
hospitalization and location of residence were recorded.
Next-generation sequence analysis
Following revision of the case report forms, patients for whom an
aetiology was not identified, but clinical evidence was suggestive of a
viral infection, were selected for next-generation sequence (NGS)
analysis. CSF samples, sera and nasopharyngeal swabs from represen-
tative patients (n= 13) were sent to PathoQuest SAS (Paris, France)
for NGS analysis using an Illumina HiSeq-2000 sequencer (DNAVi-
sion, Gosselies, Belgium). Sample preparation, sequencing and bioin-
formatic analysis was conducted as described in Gagnieur et al15
except that human genome sequence subtraction was done by
reference to NCBI build 37.1/assembly hg19.
Ethical approval
This study was approved by the Cambodian National Ethics Com-
mittee for Human Research (approval #107NECHR and
#212NECHR). All samples were collected after obtaining informed
consent from the patient’s parents or guardians. Informed consent was
also obtained for all patients to send samples internationally for NGS
analysis.
RESULTS
A total of 1160 paediatric AME cases were enroled: 930 (80.1%)
patients from Jayavarman VII Hospital in Siem Reap (from July 2010
through September 2013) and 229 (19.9%) patients from Kantha
Bopha Hospital in Phnom Penh (from February 2013 through
December 2013). The demographic characteristics of the patients
included in the study are outlined in Table 1 and a summary of the
biochemical tests used to inform the diagnosis of AME is provided in
Supplementary Table S2.
An infectious aetiology was detected in 35.0% (n= 406) of AME
cases enroled in the study using the criteria for assigning ‘confirmed’
and ‘highly probable’ cases (Table 2). When ‘suspected’ cases were also
included, the proportion of cases with an aetiology identified was
44.2% (n= 513). JEV was the most commonly detected pathogen with
20.3% of cases categorized as ‘confirmed’ or ‘highly probable’ and a
further 4.1% defined as ‘suspected’ (total 24.4%, n= 283). Other
pathogens frequently associated with AME included O. tsutsugamushi
(4.7%, n= 55), DENV1-4 (4.6%, n= 53), enterovirus/EV-A71 (3.5%,
A. Direct detection of pathogen in the CSF by PCR 
(excluding CMV or EBV) or culture, AND/OR
B. Direct detection of pathogen in the blood by PCR or 
culture
ConfirmedYes
No
A. Detection of IgM antibodies for pathogen in the CSF with  
OD CSF > OD serum, AND/OR
B. Direct detection of CMV or EBV in the CSF by PCR
Yes Highly 
probable
No
Unknown aetiology
A. IgM seroconversion or increased titre to the pathogen 
from paired sera
B. Detection of EV71 or enterovirus in throat and rectal 
swab – in the absence of other diagnosis
SuspectedYes
No
Figure 1 The diagnostic algorithm used for the study.
PCR/Isolation from CSFa PCR/Isolation from blood
Confirmed
IgM detection in the CSFb,c
Highly probable
IgM detection in the blooda,d
Suspected
Enterovirus detection in
throat or rectal swab
Figure 2 A decision tree used in the study to prioritize the importance of results in determining the final conclusion for aetiology. Ranking of the primacy of
results is from left (most reliable) to right (least reliable). aDetection of CMV or EBV in the CSF was categorized as ‘highly probable’ due to the possibility of
reactivation of latent virus. bIgM detection was considered positive when the optical density (OD) of the samples was greater than the mean OD of three
negative control samples plus 3 standard deviations. cIgM detection in the CSF was only considered positive when the CSF IgM titre was higher than blood
IgM titre for the corresponding virus. dAn acute infection was defined as a significant increase in OD measured for IgM by ELISA between admission and
discharge sera.
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n= 41), CHIKV (2.0%, n= 23) and S. pneumomiae (1.6%, n= 19).
Conflicting results were detected in 16 patients and included instances
where two or more pathogens with a classification of ‘confirmed’ or
‘highly probable’ were detected. Patients with conflicting results also
included five cases where two or three pathogens were detected in a
patient’s CSF by molecular testing. These results were included in the
aetiology counts (Table 2), but these cases were also included in
Supplementary Table S3 for further scrutiny.
NGS analysis of the CSF with negative targeted screening did not
result in the detection of any pathogens in AME patients. NGS analysis
of nasopharyngeal swabs from representative patients (n= 13) resulted
in the detection of common respiratory viruses in some samples
(human parainfluenza virus 4, human metapneumovirus, human
respiratory syncytial virus). Targeted real-time RT-PCR testing of
the respective CSF samples from these patients did not detect the
presence of these respiratory viruses in the central nervous system of
the patients.
The demographic characteristics of infection were analyzed for all
pathogens detected in 4ten cases of AME using data from ‘confirmed’
or ‘highly probable’ aetiology (Table 3). JEV was more commonly
detected in children aged one to ten years with a median age of five
years. Whereas, DENV and CHIKV-associated AME cases were more
evenly distributed amongst the age groups (median ages of six and
seven, respectively). Enterovirus and S. pneumoniae infections were
more commonly detected in younger children (median age of four for
both), particularly children between one to five years. O. tsutsugamushi
cases were more commonly associated in older children, with a median
age of eight years. There was no significant difference in the gender
distribution of JEV, DENV, enterovirus, S. pneumoniae or O. tsutsuga-
mushi cases when compared to the whole study population. However,
there was a highly significant gender difference in AME cases associated
with CHIKV, with 16 male patients and only 1 female patient enroled.
The characteristics of JEV infection in Cambodia were analyzed to
highlight the time and geographical distribution of JEV in the country
and the presence of ‘hotspots’ for infection (Figures 3 and 4). Other
aetiologies were not analyzed in this manner due to the much lower
number of cases. JEV cases were overwhelmingly identified in the
West/Northwest of Cambodia (2010–2012 recruitment in Jayavarman
VII hospital, Siem Reap). When recruitment took place in both
Table 1 Demographic characteristics of the study participants
Characteristics Siem Reap Phnom Penh Total
Number of patients 931 229 1160
Date range July 2010–
September 2013
February–
December 2013
July 2010–
December 2013
Age
Range 1 month–15 years 2 months–15 years 1 month–15 years
Median 6 years 5 years 6 years
1–11 months 36 (3.9%) 10 (4.5%) 46 (4.0%)
1–5 years 422 (45.3%) 107 (46.7%) 529 (45.6%)
6–10 years 255 (27.4%) 67 (29.3%) 322 (27.8%)
11–15 years 217 (23.3%) 40 (17.5%) 257 (22.2%)
Unknown 1 (0.1%) 5 (2.2%) 6 (0.5%)
Sex
Female 381 (40.9%) 102 (44.5%) 483 (41.6%)
Male 550 (59.1%) 126 (55.0%) 676 (58.3%)
Unknown 0 1 (0.4%) 1 (0.09%)
Table 2 Laboratory results to determine the aetiology of acute meningoencephalitis in Cambodian children
Pathogena Confirmed
Highly probable
CSF IgM or PCR detection
of CMV or EBV in CSF
Suspected
Blood IgM or EV71 throat
and rectal PCR
Total
(n=1,160)
CSF—PCR
or Culture
Blood—PCR
or Culture Total
Japanese encephalitis virus 3 0 3 (0.3%) 233 (20.1%) 47 (4.1%) 283 (24.4%)
Dengue virus 1 10b 6b 16 (4.4%)
Dengue virus 2 3c 2c 5 (0.4%) 5 (0.4%) 25 (2.2%) 53 (4.6%)
Dengue virus 3 0 1 1 (0.09%)
Dengue virus 4 0 1 1 (0.09%)
Flavivirus 0 0 0 8 (0.7%) 20 (1.7%) 28 (2.4%)
Chikungunya virus 7d 4d 11 (0.9%) 6 (0.5%) 6 (0.5%) 23 (2.0%)
Enterovirus 22 0 22 (1.9%) NA NA 22 (1.9%)
Enterovirus 71 9 0 9 (0.8%) NA 10 (0.9%) 19 (1.6%)
Herpes simplex virus 11 NA 11 (0.9%) NA NA 11 (0.9%)
Epstein-Barr virus NA NA NA 10 (0.9%) NA 10 (0.9%)
Cytomegalovirus NA NA NA 5 (0.4%) NA 5 (0.4%)
Streptococcus pneumoniae 19 0 19 (1.6%) NA NA 19 (1.6%)
Haemophilus influenzae 8 0 8 (0.7%) NA NA 8 (0.7%)
Neisseria meningitidis 2 0 2 (0.2%) NA NA 2 (0.2%)
Orientia tsutsugamushi 4e 51e 55 (4.7%) NA NA 55 (4.7%)
Totalf NA NA 141 (12.2%) 265 (22.8%) 107 (9.2%) 513 (44.2%)
Abbreviations: cytomegalovirus, CMV; cerebrospinal fluid, CSF; Epstein-Barr virus, EBV; immunoglobulin, IgM; not applicable, NA.
a Only pathogens detected in the study are included in the table.
b2 cases were positive in both CSF and blood, 8 cases were positive in CSF only, 6 cases were positive in blood only.
c1 case was positive in both CSF and blood, 2 cases were positive in CSF only, 2 cases were positive in blood only.
d6 cases were positive in both CSF and blood, 1 case was positive in CSF only, 4 cases were positive in blood only.
e4 cases were positive in both CSF and blood, 0 cases were positive in CSF only, 51 cases were positive in blood only.
fOnly the number of patients were included in the total amounts (i.e. a coinfection with two pathogens was not counted twice).
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hospitals (Kantha Bopha in Phnom Penh additionally to Jayavarman
VII in Siem Reap), a more comprehensive understanding of JEV
epidemiology in Cambodia was obtained: cases occurred throughout
the country, albeit at a lower attack rate in the South/Southwest. The
population-adjusted attack rate in 2013 remained comparable to
2010–2012 in the West/Northwest of the country but Banteay Mean-
chey and the sparsely populated province of Preah Vihear seemed to
suffer a disproportionate burden.
DISCUSSION
The pathogens targeted for testing in this study were selected based on
pre-existing data from the region on the most likely aetiologies of
AME. The detection of confirmed or highly probably aetiologies in
35.0% (44.2% including ‘suspected’ cases) of cases was comparable to
previous studies in Thailand (n= 149) and Vietnam (n= 1241) during
which confirmed or probable aetiologies were identified in 36% of
cases and 52% of AME patients, respectively.16,17 Moreover, the NGS
analysis did not identify other important pathogens that should have
been included in the targeted testing. As such, we are confident that
the main aetiologies of AME in Cambodia, identifiable in CSF and
peripheral samples, are described.
JEV was only detected by molecular testing or culture analysis in the
CSF of three patients. The difficulties of direct detection of JEV in
encephalitis patients is well documented and is likely related to the low
viral load in CSF and plasma during infection. Using serological and
molecular testing, JEV was the most common cause of AME in this
study, with 20.3% of cases ‘confirmed’ or ‘highly probable’ for JEV
infection; and a further 4.1% classified as ‘suspected’. These findings
support previous studies conducted in Cambodia,11,18,19 and indeed the
region,8,17,20–22 reporting JEV as the main cause of infectious paediatric
encephalitis. These findings should provide impetus for initiatives to
further roll out JEV vaccination in the region. Currently JEV vaccination
is not widespread in Cambodia. However, a nationwide JEV vaccination
programme has recently been announced (1 March 2016).23
Mapping of JEV cases showed a backdrop ofo1 diagnosed case per
100 000, with a higher burden in the North/Northwest than in the
Southeast of Cambodia, which is home to 2/3 of the Cambodian
population.24 This may be due to the Northwest being more agrarian
and sparsely populated except in some urbanized Districts. It may also
be due to a higher pig-raising activity in that area.25 Conversely, fewer
cases per 100 000 pop (2012) may have been detected in the Southeast
hospital network due to more diversified healthcare options in that
part of Cambodia.24
In Southern Asia, O. tsutsugamushi— the agent of scrub typhus— is
a common, but underappreciated cause of AME. Neurological compli-
cations have commonly been described in scrub typhus cases in India
and Thailand;26–29 and O. tsutsugamushi was associated with 6.1%
(6/98) and 2.8% (31/1112) of AME cases in Thailand and Vietnam,
respectively.16,30 In the present study, O. tsutsugamushi was the second
most common aetiology identified, with bacteremia detected by qPCR
in 4.7% (n= 55) of AME patients. In four (overall 0.3%) of these
patients O. tsutsugamushi DNA was also detected in the CSF of the
patients. These results closely reflect a study conducted in Laos that
reported O. tsutsugamushi as the aetiology of CNS infections in 2.9%
(n= 1051) of patients by PCR or culture (detected in CSF and blood in
2.0% and 3.1% of patients, respectively).30 Cambodian cases were more
commonly detected in older children, which is consistent with the
epidemiology of scrub typhus as O. tsutsugamushi is transmitted through
the bite of trombiculid mites (chiggers), usually found in vegetated
areas. Adults and older children are therefore more likely to be infected
by this organism, as previously reported in Cambodia and Vietnam.31 It
is very important that clinicians in Cambodia and the region consider O.
tsutsugamushi in cases of AME as the infection is readily treatable
through timely and adequate antibiotic therapy.32
Enteroviruses and EV-A71 were detected by RT-qPCR in the CSF of
1.9% (n= 22) and 0.8% (n= 9) of AME cases, respectively. Suspect
cases (n= 10) of EV-A71 encephalitis were also identified through the
concurrent detection of the virus in both oropharyngeal and rectal
swabs from the same patient, indicating systemic infection. Prior to the
enrolment of patients from Kantha Bopha Hospital in Phnom Penh, a
large outbreak of encephalitis associated with EV-A71 was reported
from this hospital.33 During this outbreak (April–July 2012) at least 56
young children died from severe encephalitis and pulmonary oedema
associated with EV-A71 infection. Although fairly low numbers of EV-
A71 were detected throughout the current study, the outbreak in
201233 and a subsequent outbreak in 2014,34 highlight the importance
of this pathogen in AME cases in Cambodia and the region.
Although reports of dengue infections associated with neurological
symptoms have been recorded in the literature for many years,10 until
recently it has not been generally accepted that DENV was an
important cause of encephalitis. Previous studies in the Southeast
Asia region have identified DENV as the aetiology of AME in 5.1%
(5/99), 4.6% (9/194) and 1.3% (2/149) of cases in Cambodia,11
Vietnam21 and Thailand,16 respectively. In the present study, DENV
was ‘confirmed’ or ‘highly probable’ in 2.4% (n= 28) of cases (4.6% if
‘suspected’ cases are also included). Using molecular testing DENV1
(n= 16) and DENV2 (n= 5) were the main serotypes detected, which
corresponded to a period where DENV1 and DENV2 were the
predominant dengue serotypes circulating in the country.35,36
The detection of CHIKV was characterized as ‘confirmed’ or ‘highly
probable’ in 11 (0.9%) and six (0.5%) AME cases, respectively; a
further six ‘suspected’ cases were detected through blood serology. This
Table 3 Age and gender characteristics for patients in which the main pathogens were detected
Pathogen detecteda Gender ratio (M:F) Median age (years) Age groups (% of total number in age group)
1–11 months 1–5 years 6–10 years 11–15 years
JEV 1.6 (144:92) 5 1 (2.2%) 119 (22.5%) 85 (26.4%) 30 (11.7%)
DENV1-4 1.5 (17:11) 6 2 (4.3%) 12 (2.3%) 9 (2.8%) 5 (1.9%)
CHIKV 16 (16:1) 7 0 8 (1.5%) 4 (1.2%) 5 (1.9%)
Enterovirusb 1.8 (20:11) 4 0 19 (3.6%) 9 (2.8%) 3 (1.2%)
S. pneumoniae 1.4 (11:8) 4 0 12 (2.3%) 4 (1.2%) 3 (1.2%)
O. tsutsugamushi 1.4 (32:23) 8 1 (2.2%) 18 (3.4%) 11 (3.4%) 25 (9.7%)
Baseline 1.4 (676:483) 6 n=46 n=529 n=322 n=257
Abbreviations: chikungunya virus, CHIKV; dengue virus, DENV; Japanese encephalitis virus, JEV.
aConfirmed and highly probable aetiologies.
bIncluding EV-A71.
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Figure 3 Population-adjusted attack rates (cases per 100 000 pop, using 2012 population) of Japanese encephalitis virus for the 2010–2012 study period
(A) and 2013 study period (B) mapped using ArcGIS 10 (Esri, Redlands, CA, USA), by year and patient’s province of residence, to assess the time and
geographical distribution of ‘confirmed’ and ‘highly probable’ cases. Population density across Cambodia was also mapped, using villages as a proxy for
population (each village being represented as one dot). Note: The number of hospitals participating in the surveillance system differed between the two
periods. The maps therefore use different scales to illustrate the relative incidence and burden of JEV by province during those periods rather than absolute
incidence values.
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virus was first linked with severe neurological illnesses during
the explosive outbreaks in the Indian Ocean and India during
2005–2006.37–39 However, CHIKV has rarely been directly detected in
the CSF of AME patients. As such, the detection of CHIKV in the CSF
of seven patients by RT–qPCR and/or culture in this study is
noteworthy. All CHIKV AME cases were detected between June 2011
and October 2012, corresponding to a period when an outbreak of
chikungunya was ongoing in Cambodia.14,40 Interestingly, this outbreak
was only identified following the detection of ‘sentinel’ encephalitis
cases reported in the present study, leading to confirmation of the
outbreak through community-based investigations.14,41 The majority of
CHIKV-associated AME cases were detected in males with a significant
difference in the gender ratio (male:female ratio of 16). Severe CHIKV
infection was more commonly observed in males in the large outbreak
in India,39 whereas severe cases were more commonly reported in
females in the Reunion Island outbreak.37 We do not know of any
reasons why there would be such a marked difference in the gender
ratio of Cambodian CHIKV AME cases as the demographic data and
results from other aetiologies do not suggest a gender bias in the
recruitment of cases.
The herpesviruses HSV, EBV and CMV were detected by PCR in
the CSF of 0.9% (n= 11), 0.9% (n= 10) and 0.4% (n= 5) of AME
cases, respectively. These pathogens are commonly reported as the
main aetiology of infectious AME in developed countries.42–45 In
developing countries worldwide, however, other aetiological agents
such as arboviruses are more commonly detected.
The vaccine-preventable bacterial species commonly associated with
meningitis, S. pneumoniae, H. influenzae type B and N. meningitidis,
were detected in 1.6% (n= 19), 0.7% (n= 8) and 0.2% (n= 2) of AME
cases, respectively. These results are consistent with other studies in
Vietnam, Thailand and Bangladesh with S. pneumoniae detected in
5.7%, 3.0% and 5.7%; H. influenzae type B detected in 0%, 1.0% and
0.7%; and N. meningitidis detected in 0.6%, 3.0% and 1.4% of AME
cases, respectively.16,17,46 CSF bacterial culture at the hospital sites did
not result in the isolation of any of these pathogens throughout the
study. The high use of over-the-counter antibiotic self-medication in
our setting is likely to influence isolation rates in blood and CSF
cultures.47 H. influenzae type B vaccination was introduced into the
Cambodian immunization schedule in 2008 and has likely resulted in
a considerable reduction in cases. In contrast, the pneumococcal
conjugate vaccine was introduced into the country in 2015 and the
meningococcal vaccine has not yet been introduced; thus vaccination
for these bacterial pathogens was not widespread during the study
period, 2010–2013.
Our study has important limitations, including the lack of outcome
and severity of illness data. Serological testing was focused only on
arboviruses and may have led to an underestimation of other viral and
bacterial causes of AME. Although tuberculosis is believed to be an
important cause of AME in Cambodia the current lack of reliable and
sensitive diagnostic methods for extra-pulmonary infections of M.
tuberculosis may result in a gross underestimation of the AME burden
attributable to this organism.48 It has been estimated that approxi-
mately one-third of all encephalitis cases are caused by immune-
mediated pathogenesis.49 These factors were not addressed in this
study and may be associated with a significant proportion of the
55.8% of cases where an aetiology was not determined.
In conclusion, our study identified JEV, O. tsutsugamushi, DENV,
CHIKV, enteroviruses and S. pneumoniae as the main causes of AME
in Cambodia. Therefore highlighting that the major infectious causes
of AME in the country were vaccine-preventable (e.g. JEV, DENV,
S. pneumoniae) or treatable with timely and adequate use of
antimicrobials (for example, S. pneumoniae, O. tsutsugamushi). This
first study to identify the major aetiologies of encephalitis in Cambodia
has led to the establishment of a comprehensive project, called the
Southeast Asia Encephalitis Project (SEAe, https://research.pasteur.fr/
en/program_project/the-southeast-asia-encephalitis-project/), in which
exhaustive laboratory identification of encephalitis pathogens, coupled
with development of laboratory and clinical capacity in local hospitals
is being undertaken in Cambodia, Laos, Vietnam and Myanmar.
Through these initiatives we hope to increase awareness of
encephalitis aetiologies among clinicians and improve laboratory
capacity in hospitals to reduce the morbidity and mortality associated
with AME.
Figure 4 Representation of Japanese encephalitis virus cases by month with mean rainfall data estimated by satellite teledetection (Tropical Rainfall
Measuring Mission, NASA, USA, http://trmm.gsfc.nasa.gov/) and adjusted for surface of province of residence.
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